Best Rising Stocks To Invest In Right Now

NEW YORK (TheStreet) -- Several large regional U.S. banks took it on the chin Thursday, with shares sliding 4%.

Regional banks seeing 4% declines included KeyCorp (KEY) of Cleveland, which closed at $11.60 and Regions Financial (RF) of Birmingham, Ala., closed at $9.21.

The broad indices ended mixed, after the euphoria of the decision Wednesday by the Federal Open Market Committee to leave Federal Reserve economic stimulus unchanged, wore off. The FOMC decided not to taper the central bank's "QE3" long-term bond purchases from a monthly pace of $85 billion. The Fed has expanded its balance sheet at this rate since last September.

Bank stocks were weak on Thursday. The KBW Bank Index (I:BKX) was down 1.4% to close at 63.77, with all but one of 24 index components ending with declines. The decision for the Fed not to lower bond purchases took most market watchers by surprise, and was greeted with enthusiasm Wednesday by the broad market. But bank stock investors need to worry about the Fed's main policy tool -- the federal funds rate, which has remained in range of zero to 0.25% since late 2008. The FOMC made a slight change in its language from the previous statement, saying its "highly accommodative" policy for short-term rates would "remain appropriate" at least until the national unemployment rate drops below 6.5%, assuming inflation projections remain in check, but added that it was likely to keep the federal funds rate in its current range "for a considerable time after the asset purchase program ends and the economic recovery strengthens." That's bad news for many regional bankers. Long-term interest rates have been rising, as investors have anticipated a tapering of the Fed's bond purchases. But many banks need a parallel rise in interest rates to see a significant boost to their net interest margins and net interest income. And that may take until at least late next year, depending on how accurate the FOMC's revised economic forecasts turn out to be. JPMorgan Chase The nation's largest bank holding company early Thursday was ordered by four regulators to pay $920 million in fines resulting from investigations of events leading to the "London Whale" hedge trading losses that totaled at least $6.2 billion during 2012.

Hot Cheapest Stocks To Invest In 2016: Wasgau Produktions & Handels AG (MSH)

Wasgau Produktions & Handels AG is a Germany-based retailer and producer of food articles. The Company divides its business activities into the two main segments Wholesale and Retail. The Wholesale�� businesses include seven Cash and Carry markets for restaurateurs and wholesale customers, as well as commercial businesses of the holding company WASGAU Produktions & Handels AG, which are supported by its subsidiary WASGAU Dienstleistungs & Logistik GmbH, active within warehouse management and transportation. The Operations within the Retail segment are mainly carried out through Company�� subsidiaries WASGAU Metzgerei GmbH and WASGAU Baeckerei & Konditorei GmbH, which produce and supply its stores with a variety of meats and bakery products, respectively. As of December 31, 2011, the Company operated through 24 affiliated companies and subsidiaries located in Germany. Advisors' Opinion:

• [By Benjamin Pimentel]

  The Nasdaq Composite Index (COMP) �gained 6 points, or 0.1%, to close at 4,358. The Morgan Stanley High Tech 35 Index (MSH) �and the Philadelphia Semiconductor Index (SOX) �were each up a fraction.

• [By Benjamin Pimentel]

  The Morgan Stanley High Tech 35 Index (MSH) �gave up 1.1%, while the Philadelphia Semiconductor Index (SOX) �shed 0.6%. The Dow Jones Industrial Average (DJIA) �fell 153 points as the conflict in Ukraine intensified.

• [By Benjamin Pimentel]

  The Nasdaq Composite Index (COMP) �gave up 6 points to close at 4,352. But the benchmark ended the week up 1%. The Morgan Stanley High Tech 35 Index (MSH) �also was down a fraction on Friday, while the Philadelphia Semiconductor Index (SOX) was up 0.7%.

Best Rising Stocks To Invest In Right Now: MRG Metals Ltd (MRQ)

MRG Metals Limited is engaged in mineral exploration and production in Western Australia. The Company�� projects include the Xanadu gold project, the Mulgul copper prospect, the Braemore Battery prospect-Leonora, Diorite-Leonora and the Bellchambers. The Xanadu project consists of 14 prospecting license applications cover a total area of 26.7 square kilometers. The Mulgul exploration license application covers 336 square kilometers and is located 200 kilometers north of Meekatharra. The Company is acquiring nine granted prospecting licenses covering an area of 14.8 square kilometers, located five kilometers north of Leonora in the North-eastern Goldfields of Western Australia. Diorite is located 25 kilometers north of Leonora. There are three granted prospecting licenses covering an area of 5.42 square kilometers of greenstone lithologies. Effective June 28, 2013, MRG Metals Ltd (MRG) acquired Sasak Resources Australia Pty Ltd. Advisors' Opinion:

• [By Chuck Carnevale]

  In addition to rewarding their shareholders through dividend increases and capital appreciation, Aflac has also been using its prodigious cash flows to purchase shares and reduce share count. Fewer shares outstanding support their ability to grow earnings per share to the benefit of shareholders. Common shares outstanding have fallen from 531 million shares in fiscal 1998 to 466 million shares in their most recent quarter (MRQ).

Best Rising Stocks To Invest In Right Now: Dorman Products Inc.(DORM)

Dorman Products, Inc. supplies automotive replacement parts, fasteners, and service line products primarily for the automotive aftermarket. The company offers approximately 128,000 products comprising original equipment dealer parts, which include intake manifolds, exhaust manifolds, oil cooler lines, window regulators, radiator fan assemblies, power steering pulleys, and harmonic balancers; and replacement parts, such as window handles and switches, door hardware, interior trim parts, headlamp aiming screws and retainer rings, radiator parts, battery hold-down bolts and repair kits, valve train parts, and power steering filler caps. It also provides application specific and general automotive hardware, such as body hardware, general automotive fasteners, oil drain plugs, and wheel hardware; a selection of electrical connectors, wires, tools, testers, and accessories; and a line of home hardware and home organization products designed for retail merchandisers. In addition, the company offers a brake and clutch program; remanufactured automotive replacement parts, such as transfer case modules and instrument clusters; and heavy duty aftermarket parts for class 4-8 heavy vehicles, including coolant tubes, door handles and other body parts, fluid reservoirs, headlights and lighting, hood components, window regulators, and wiper transmissions. It sells its products under the OE Solutions, HELP!, AutoGrade, FirstStop, Conduct-Tite!, Pik-A-Nut, and HD Solutions brand names through automotive aftermarket retailers; national, regional, and local warehouse distributors; specialty markets; and salvage yards in the United States, Mexico, Europe, the Middle East, Asia, and Canada. The company, formerly known as R&B, Inc., was founded in 1978 and is headquartered in Colmar, Pennsylvania.

Advisors' Opinion:

• [By Vera Yuan]

  During the quarter, the Fund initiated positions in eight companies and strategically added to positions in sixteen companies. Over the same time period, the Fund eliminated its holdings in six companies and strategically decreased its holdings in another five companies. Positions initiated during the last three months include: Dorman Products, Inc. (DORM), Dover Corp. (DOV), DSW Inc. (DSW), First Niagara Financial Group (FNFG), Packaging Corporation of America (PKG), Patterson Companies, Inc. (PDCO), The Travelers Companies Inc. (TRV), and Universal Health Services Inc (UHS). Positions eliminated during the past quarter include: ABB Ltd. (ABB), Ann Inc. (ANN), Baxter International (BAX), International Game Technology (IGT), TRW Automotive Holdings (TRW), and URS Corporation (URS).

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Dorman Products (Nasdaq: DORM  ) , whose recent revenue and earnings are plotted below.

Best Rising Stocks To Invest In Right Now: CareFusion Corp (CFN)

CareFusion Corporation (CareFusion), incorporated on January 14, 2009, is a global medical technology company. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company�� Medical Systems segment�� business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company�� disposable products and reusable surgical instruments businesses. The Company�� Procedural Solutions segment�� business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. In August 2011, the Company acquired Rowa. In June 2012, the Company acquired U.K. Medical Limited. In July 2012, Natus Medical, Inc. acquired the Nicolet neurodiagnostic business from CareFusion. Effective December 31, 2013, CareFusion Corp acquired Vital Signs Inc from GE Healthcare, a unit of General Electric Co.

Medical Systems Segment

The Company�� develops, manufactures and markets capital equipment and related supplies for medication management, which includes its infusion and medication dispensing technologies, supply dispensing technologies and respiratory technologies. Its products are designed to enable healthcare professionals to improve patient safety by reducing medication errors and improving administrative controls, while simultaneously improving workflow and increasing operational efficiency. The Company sells these products primarily through its direct sales force, but use third-party distributors as well, particularly outside the United States. Many of its products in this segment are integrated with other information systems within the hospital, including financial and business systems that support patient admissions, discharges and transfers, operational systems that include inventory management and clinical systems that include pharmacy inf! ormation and electronic medical records.

The Company offers value-added services and programs, software technical services and clinical education, which are designed to enhance its customers��utilization of its medical equipment products. The Company�� project management, field service organization and customer call centers support its customers before, during and after product installation. The Company�� project management teams assist customers with the development of project implementation plans, which are designed to ensure rapid, seamless implementation of its products. The Company�� field service organization provides on-site expertise to resolve customers��service issues. The Company�� customer call centers provide additional support to its customers.

The Company is engaged in designing, developing and marketing of IV infusion systems that deliver medications and other fluids directly into a patient�� veins in precise, measured quantities over a range of infusion rates. The Company is provider of point-of-care systems that automate the dispensing of medications and supplies in hospitals and other healthcare facilities in the United States. The Company develops, manufactures, markets and services mechanical ventilators and associated consumables for patients with respiratory disorders.

The Company competes with Baxter International, B. Braun, Fresenius Kabi, Hospira, Omnicell, McKesson; Drager, and MAQUET.

Procedural Solutions Segment

The Procedural Solutions segment is organized around its disposable products and reusable surgical instruments businesses. In its Procedural Solutions segment, the Company develops, manufactures and markets single-use skin antiseptic and other patient-preparation products, non-dedicated IV infusion administration sets and accessories, reusable surgical instruments and non-dedicated ventilator circuits and other disposables used for providing respiratory therapy. The products in this segm! ent are u! sed in the operating room, interventional suites, and in the critical care departments of hospitals. The Company sells these products and services through a combination of direct sales representatives and third-party distributors.

The Company�� Infection Prevention business unit consists mainly of single-use medical products used in surgical and vascular access procedures, including skin preparation products and disposable IV infusion administration sets and accessories. The Company�� Medical Specialties business unit consists mainly of specialty medical devices used in delivering interventional care and reusable surgical instrumentation products. The Company�� Specialty Disposables business unit focuses on providing clinicians with respiratory consumable products that work either independently or in conjunction with its range of ventilators.

The Company competes with 3M, ICU Medical, Becton, Dickinson, Baxter International, B. Braun; Hospira; Smiths Medical; CR Bard, Integra Life Sciences, and Teleflex.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on CareFusion (NYSE: CFN  ) , whose recent revenue and earnings are plotted below.

• [By Alanna Petroff]

  Medical technology firm Becton, Dickinson and Co (BDX) is taking over CareFusion (CFN) in a cash and stock deal that values CareFusion shares at $58 each.

• [By Sean Williams]

  Heading notably higher as well, up 5.5%, was medical-products supplier CareFusion (NYSE: CFN  ) which is said to be in talks as a possible acquirer of Britain-based Smiths Group's medical division. Although neither company would comment on a potential sale it would clearly be a positive for CareFusion since its revenue growth has stagnated in recent years. We should hopefully know more about these developments over the coming weeks.

Best Rising Stocks To Invest In Right Now: Brown-Forman Corp (BF.B)

Brown-Forman Corporation, incorporated on October 19, 1933, primarily manufactures, bottles, imports, exports, markets, and sells a variety of alcoholic beverage brands. The Company�� principal brands are Jack Daniel�� Tennessee Whiskey, Jack Daniel�� Tennessee Whiskey, Pepe Lopez Tequilas, Jack Daniel�� Single Barrel, Woodford Reserve Bourbons, Jack Daniel�� Ready-to-Drinks, Canadian Mist Blended Canadian Whiskies, Jack Daniel�� Tennessee Honey, Chambord Liqueur, Jack Daniel�� Winter Jack Chambord Vodka, Gentleman Jack, Collingwood Canadian Whisky, Southern Comfort, Early Times Bourbon, Southern Comfort Ready-to-Drinks, Early Times flavored line extensions, Southern Comfort flavored line extensions, Early Times Kentucky Whisky, Finlandia Vodkas, Korbel California Champagnes, Finlandia Ready-to-Drinks, Little Black Dress Vodkas, Antiguo Tequila, Maximus Vodkas, el Jimador Tequilas, Old Forester Bourbon, el Jimador New Mix Ready-to-Drinks, Sonoma-Cutrer Wines, Herradura Tequilas, and Tuaca Liqueur.

The Company�� products are sold in more than 150 countries around the world. The Company�� international markets include Australia, the United Kingdom, Mexico, Germany, Poland, France, Russia, Japan, Turkey, Canada, Spain, Czech Republic, South Africa, Brazil and Italy.

The Company competes with Bacardi Limited, Beam Inc., Davide Campari-Milano S.p.A., Diageo plc, LVMH Moet Hennessy Louis Vuitton S.A., Pernod Ricard S.A., and Remy Cointreau S.A.

Advisors' Opinion:

• [By John Udovich]

  Whiskey has become increasingly cool and popular thanks to the whole cocktail movement, something that�� good for big whiskey stocks like Suntory Beverage & Food Limited (OTCMKTS: STBFY), Diageo plc (NYSE: DEO) and Brown-Forman Corporation (NYSE: BF.B) who�also produce a wide variety of�liquors and beverages. In fact,�a recent episode of the�Daily Ticker�cited these stats from a USA Today article:

• [By Holly LaFon]

  TR: Definitely. The most likely places that they��l probably pop up are counterparts to the same businesses that we already own because the economics are good for Richemont (XSWX:CFR). They sell precious jewelry and luxury goods and watches to aspirational consumers around the world. The same economics drive Swatch. I don�� own Swatch, in big measure. I own it for a handful of clients. But that�� kind of the natural sourcing ground for me. I don�� own Compari. I do own Pernod Ricard (PDRDF), Diageo (DEO), Brown Forman (BF.B). Compari�� a great company. They have different brands and strengths in different categories than the three companies that we already own. I could own Compari.

Best Rising Stocks To Invest In Right Now: Hanger Orthopedic Group Inc.(HGR)

Hanger Orthopedic Group, Inc. engages in the ownership and operation of orthotic and prosthetic (O&P) patient care centers in the United States. The company provides orthotic and prosthetic patient care services. Its orthotics business include the design, fabrication, fitting, and maintenance of a range of standard and custom-made braces and other devices that provide external support to patients suffering from musculoskeletal disorders, such as ailments of the back, extremities or joints, and injuries from sports or other activities. The company?s prosthetics business comprise designing, fabricating, fitting, and maintaining custom-made artificial limbs for patients, who are without limbs as a result of traumatic injuries, vascular diseases, diabetes, cancer, or congenital disorders. It also distributes branded and private label O&P devices, as well as develops programs to manage various aspects of O&P patient care for insurance companies. In addition, the company manufac tures and distributes therapeutic footwear for diabetic patients in the podiatric market, as well as develops and provides specialized rehabilitation technologies and integrated clinical programs to rehabilitation providers. As of June 30, 2011, it operated approximately 675 patient-care centers in 45 states and the District of Columbia. The company, formerly known as Sequel Corporation, was founded in 1861 and is headquartered in Austin, Texas.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]

  Alamy There are plenty of stocks going up -- and down -- in any given week. The gainers inspire us to keep investing. The decliners keep greed in check while reminding us about the risks of the equity markets. Let's go over some of last week's best and worst performers. Pike (PIKE) -- Up 49 percent last week The market's biggest winner of last week was Pike, a specialty construction and engineering firm that received a bid to be taken private. J. Eric Pike -- the firm's chairman and CEO -- is teaming up with private equity firm Court Square Capital Partners to buy out shareholders at $12 a share. It's a fair premium, pricing the buyout at a better than 50 percent premium to where the stock was trading when it was announced. A few attorneys are trying to smoke out investors who feel that the CEO-led privatization push isn't fair, but it's likely to stick at that kind of healthy markup. Pike shares may have traded in the low teens last summer, but that was before revenue and earnings began heading the wrong way. Most shareholders should be more than happy to take the money and run. RadNet (RDNT) -- Up 34 percent last week Operating a network of 251 facilities that perform outpatient diagnostic imaging services is looking good for RadNet. The stock moved sharply higher after a strong quarterly report. Revenue inched slighting higher as MRI and CT scan volume increased modestly during the period. However, the real star in the report was RadNet's bottom line. Its cost-cutting and debt-slashing efforts paid off with net income soaring to $0.12 a share after clocking in at a $0.07 a share a year earlier. Analysts were only holding out for $0.05 a share. RadNet also helped improve its standing by boosting its guidance for all of 2014. You don't need any of RadNet's fancy imaging equipment to see that that's a healthy sign. Trex (TREX) -- Up 25 percent last week It was a good week for a pair of home improvement specialists. Shares of CaesarStone (CSTE) moved 20